These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 30354950)

  • 1. Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU.
    Krag M; Marker S; Perner A; Wetterslev J; Wise MP; Schefold JC; Keus F; Guttormsen AB; Bendel S; Borthwick M; Lange T; Rasmussen BS; Siegemund M; Bundgaard H; Elkmann T; Jensen JV; Nielsen RD; Liboriussen L; Bestle MH; Elkjær JM; Palmqvist DF; Bäcklund M; Laake JH; Bådstøløkken PM; Grönlund J; Breum O; Walli A; Winding R; Iversen S; Jarnvig IL; White JO; Brand B; Madsen MB; Quist L; Thornberg KJ; Møller A; Wiis J; Granholm A; Anthon CT; Meyhoff TS; Hjortrup PB; Aagaard SR; Andreasen JB; Sørensen CA; Haure P; Hauge J; Hollinger A; Scheuzger J; Tuchscherer D; Vuilliomenet T; Takala J; Jakob SM; Vang ML; Pælestik KB; Andersen KLD; van der Horst ICC; Dieperink W; Fjølner J; Kjer CKW; Sølling C; Sølling CG; Karttunen J; Morgan MPG; Sjøbø B; Engstrøm J; Agerholm-Larsen B; Møller MH;
    N Engl J Med; 2018 Dec; 379(23):2199-2208. PubMed ID: 30354950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pantoprazole in ICU patients at risk for gastrointestinal bleeding-1-year mortality in the SUP-ICU trial.
    Marker S; Krag M; Perner A; Wetterslev J; Lange T; Wise MP; Borthwick M; Bendel S; Keus F; Guttormsen AB; Schefold JC; Rasmussen BS; Elkmann T; Bestle M; Arenkiel B; Laake JH; Kamper MK; Lång M; Pawlowicz-Dworzanska MB; Karlsson S; Liisanantti J; Dey N; Knudsen H; Granholm A; Møller MH;
    Acta Anaesthesiol Scand; 2019 Oct; 63(9):1184-1190. PubMed ID: 31282567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress Ulcer Prophylaxis during Invasive Mechanical Ventilation.
    Cook D; Deane A; Lauzier F; Zytaruk N; Guyatt G; Saunders L; Hardie M; Heels-Ansdell D; Alhazzani W; Marshall J; Muscedere J; Myburgh J; English S; Arabi YM; Ostermann M; Knowles S; Hammond N; Byrne KM; Chapman M; Venkatesh B; Young P; Rajbhandari D; Poole A; Al-Fares A; Reis G; Johnson D; Iqbal M; Hall R; Meade M; Hand L; Duan E; Clarke F; Dionne JC; Tsang JLY; Rochwerg B; Karachi T; Lamontagne F; D'Aragon F; St Arnaud C; Reeve B; Geagea A; Niven D; Vazquez-Grande G; Zarychanski R; Ovakim D; Wood G; Burns KEA; Goffi A; Wilcox ME; Henderson W; Forrest D; Fowler R; Adhikari NKJ; Ball I; Mele T; Binnie A; Trop S; Mehta S; Morgan I; Loubani O; Vanstone M; Fiest K; Charbonney E; Cavayas YA; Archambault P; Rewa OG; Lau V; Kristof AS; Khwaja K; Williamson D; Kanji S; Sy E; Dennis B; Reynolds S; Marquis F; Lellouche F; Rahman A; Hosek P; Barletta JF; Cirrone R; Tutschka M; Xie F; Billot L; Thabane L; Finfer S;
    N Engl J Med; 2024 Jul; 391(1):9-20. PubMed ID: 38875111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
    Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
    Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Prophylactic Pantoprazole in Adult Intensive Care Unit Patients Receiving Dialysis: Results of a Randomized Trial.
    Schefold JC; Krag M; Marker S; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Keus F; Guttormsen AB; Lange T; Møller MH;
    Am J Nephrol; 2019; 50(4):312-319. PubMed ID: 31480045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of pantoprazole vs. placebo on 1-year outcomes, resource use and employment status in ICU patients at risk for gastrointestinal bleeding: a secondary analysis of the SUP-ICU trial.
    Halling CMB; Møller MH; Marker S; Krag M; Kjellberg J; Perner A; Gyrd-Hansen D
    Intensive Care Med; 2022 Apr; 48(4):426-434. PubMed ID: 35122105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pantoprazole prophylaxis in ICU patients with high severity of disease: a post hoc analysis of the placebo-controlled SUP-ICU trial.
    Marker S; Perner A; Wetterslev J; Krag M; Lange T; Wise MP; Borthwick M; Bendel S; Keus F; Guttormsen AB; Schefold JC; Møller MH;
    Intensive Care Med; 2019 May; 45(5):609-618. PubMed ID: 30863936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of stress ulcer prophylaxis in adult ICU patients receiving renal replacement therapy (Sup-Icu RENal, SIREN): Study protocol for a pre-planned observational study.
    Schefold JC; Perner A; Lange T; Wetterslev J; Wise MP; Borthwick M; Bendel S; Keus F; Guttormsen AB; Marker S; Krag M; Møller MH;
    Trials; 2018 Jan; 19(1):26. PubMed ID: 29321041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical Trial and Meta-Analysis.
    Alhazzani W; Guyatt G; Alshahrani M; Deane AM; Marshall JC; Hall R; Muscedere J; English SW; Lauzier F; Thabane L; Arabi YM; Karachi T; Rochwerg B; Finfer S; Daneman N; Alshamsi F; Zytaruk N; Heel-Ansdell D; Cook D;
    Crit Care Med; 2017 Jul; 45(7):1121-1129. PubMed ID: 28459708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress ulcer prophylaxis in the intensive care unit trial: detailed statistical analysis plan.
    Krag M; Perner A; Wetterslev J; Lange T; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Meyhoff TS; Marker S; Møller MH
    Acta Anaesthesiol Scand; 2017 Aug; 61(7):859-868. PubMed ID: 28608496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Benefits and risks of stress ulcer prevention with proton pump inhibitors for critical patients: an observational cohort study with 1 972 patients].
    Sun J; Wang B; Cao P; Zhu H; Lu K; Geng P; Tan D
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):539-544. PubMed ID: 31198136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial.
    Moayyedi P; Eikelboom JW; Bosch J; Connolly SJ; Dyal L; Shestakovska O; Leong D; Anand SS; Störk S; Branch KRH; Bhatt DL; Verhamme PB; O'Donnell M; Maggioni AP; Lonn EM; Piegas LS; Ertl G; Keltai M; Cook Bruns N; Muehlhofer E; Dagenais GR; Kim JH; Hori M; Steg PG; Hart RG; Diaz R; Alings M; Widimsky P; Avezum A; Probstfield J; Zhu J; Liang Y; Lopez-Jaramillo P; Kakkar A; Parkhomenko AN; Ryden L; Pogosova N; Dans A; Lanas F; Commerford PJ; Torp-Pedersen C; Guzik T; Vinereanu D; Tonkin AM; Lewis BS; Felix C; Yusoff K; Metsarinne K; Fox KAA; Yusuf S;
    Gastroenterology; 2019 Aug; 157(2):403-412.e5. PubMed ID: 31054846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-evaluating the Utility of Stress Ulcer Prophylaxis in the Critically Ill Patient: A Clinical Scenario-Based Meta-Analysis.
    Reynolds PM; MacLaren R
    Pharmacotherapy; 2019 Mar; 39(3):408-420. PubMed ID: 30101529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
    Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
    Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pantoprazole or Placebo for Stress Ulcer Prophylaxis (POP-UP): Randomized Double-Blind Exploratory Study.
    Selvanderan SP; Summers MJ; Finnis ME; Plummer MP; Ali Abdelhamid Y; Anderson MB; Chapman MJ; Rayner CK; Deane AM
    Crit Care Med; 2016 Oct; 44(10):1842-50. PubMed ID: 27635481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress ulcer prophylaxis in critically ill adult patients with sepsis at risk of gastrointestinal bleeding: a retrospective cohort study.
    Huang M; Han M; Song Z; Kuang L
    Intern Med J; 2023 Mar; 53(3):389-396. PubMed ID: 34697866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.
    ; Young PJ; Bagshaw SM; Forbes AB; Nichol AD; Wright SE; Bailey M; Bellomo R; Beasley R; Brickell K; Eastwood GM; Gattas DJ; van Haren F; Litton E; Mackle DM; McArthur CJ; McGuinness SP; Mouncey PR; Navarra L; Opgenorth D; Pilcher D; Saxena MK; Webb SA; Wiley D; Rowan KM
    JAMA; 2020 Feb; 323(7):616-626. PubMed ID: 31950977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress ulcer prophylaxis with proton pump inhibitors or histamine 2 receptor antagonists in critically ill adults - a meta-analysis of randomized controlled trials with trial sequential analysis.
    Zhou X; Fang H; Xu J; Chen P; Hu X; Chen B; Wang H; Hu C; Xu Z
    BMC Gastroenterol; 2019 Nov; 19(1):193. PubMed ID: 31752703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pantoprazole for the prevention of gastrointestinal bleeding in high-risk patients with acute coronary syndromes.
    Wu H; Jing Q; Wang J; Guo X
    J Crit Care; 2011 Aug; 26(4):434.e1-6. PubMed ID: 21273036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of treatment effect of stress ulcer prophylaxis in ICU patients: A secondary analysis protocol.
    Granholm A; Marker S; Krag M; Zampieri FG; Thorsen-Meyer HC; Kaas-Hansen BS; van der Horst ICC; Lange T; Wetterslev J; Perner A; Møller MH
    Acta Anaesthesiol Scand; 2019 Oct; 63(9):1251-1256. PubMed ID: 31321771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.